serine has been researched along with Ataxia Telangiectasia in 22 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Ataxia Telangiectasia: An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with lactacystin (an inhibitor of the proteasome) or heat shock leads to similar levels of p53 accumulation in normal and AT fibroblasts, but the p53 protein lacks a phosphorylated serine 15." | 1.30 | Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. ( Nakagawa, K; Tamai, K; Taya, Y; Yamaizumi, M, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (13.64) | 18.2507 |
2000's | 17 (77.27) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
von Morgen, P | 1 |
Burdova, K | 1 |
Flower, TG | 1 |
O'Reilly, NJ | 1 |
Boulton, SJ | 1 |
Smerdon, SJ | 1 |
Macurek, L | 1 |
Hořejší, Z | 1 |
Gatei, M | 2 |
Kijas, AW | 1 |
Biard, D | 1 |
Dörk, T | 1 |
Lavin, MF | 2 |
Das, BB | 1 |
Antony, S | 1 |
Gupta, S | 1 |
Dexheimer, TS | 1 |
Redon, CE | 1 |
Garfield, S | 1 |
Shiloh, Y | 3 |
Pommier, Y | 1 |
Sutton, IJ | 1 |
Last, JI | 2 |
Ritchie, SJ | 1 |
Harrington, HJ | 1 |
Byrd, PJ | 2 |
Taylor, AM | 2 |
Goodarzi, AA | 2 |
Lees-Miller, SP | 2 |
Jonnalagadda, JC | 1 |
Douglas, P | 1 |
Young, D | 1 |
Ye, R | 1 |
Moorhead, GB | 1 |
Khanna, KK | 2 |
Erker, L | 1 |
Schubert, R | 1 |
Yakushiji, H | 1 |
Barlow, C | 1 |
Larson, D | 1 |
Mitchell, JB | 1 |
Wynshaw-Boris, A | 1 |
Suzuki, K | 1 |
Kodama, S | 1 |
Watanabe, M | 1 |
Siliciano, JD | 1 |
Canman, CE | 1 |
Taya, Y | 4 |
Sakaguchi, K | 1 |
Appella, E | 1 |
Kastan, MB | 4 |
Nakagawa, K | 2 |
Tamai, K | 1 |
Yamaizumi, M | 1 |
Lakin, ND | 1 |
Hann, BC | 1 |
Jackson, SP | 1 |
Pandita, TK | 1 |
Lieberman, HB | 1 |
Lim, DS | 2 |
Dhar, S | 1 |
Zheng, W | 1 |
Kim, ST | 1 |
Xu, B | 1 |
Maser, RS | 1 |
Lin, J | 1 |
Petrini, JH | 1 |
Zhao, S | 1 |
Weng, YC | 1 |
Yuan, SS | 1 |
Lin, YT | 1 |
Hsu, HC | 1 |
Lin, SC | 1 |
Gerbino, E | 1 |
Song, MH | 1 |
Zdzienicka, MZ | 1 |
Gatti, RA | 1 |
Shay, JW | 1 |
Ziv, Y | 2 |
Lee, EY | 1 |
Wu, X | 1 |
Ranganathan, V | 1 |
Weisman, DS | 1 |
Heine, WF | 1 |
Ciccone, DN | 1 |
O'Neill, TB | 1 |
Crick, KE | 1 |
Pierce, KA | 1 |
Lane, WS | 1 |
Rathbun, G | 1 |
Livingston, DM | 1 |
Weaver, DT | 1 |
Delia, D | 1 |
Mizutani, S | 1 |
Panigone, S | 1 |
Tagliabue, E | 1 |
Fontanella, E | 1 |
Asada, M | 1 |
Yamada, T | 1 |
Prudente, S | 1 |
Saviozzi, S | 1 |
Frati, L | 1 |
Pierotti, MA | 1 |
Chessa, L | 1 |
Scott, SP | 1 |
Filippovitch, I | 1 |
Soronika, N | 1 |
Weber, B | 1 |
Yang, DQ | 1 |
Stewart, ZA | 1 |
Tang, LJ | 1 |
Pietenpol, JA | 1 |
Kishi, S | 1 |
Zhou, XZ | 1 |
Khoo, C | 1 |
Hill, DE | 1 |
Lu, KP | 1 |
Stewart, GS | 1 |
Stankovic, T | 1 |
Haites, N | 1 |
Kidd, AM | 1 |
Yoshida, M | 1 |
Hosoi, Y | 1 |
Miyachi, H | 1 |
Ishii, N | 1 |
Matsumoto, Y | 1 |
Enomoto, A | 1 |
Yamada, S | 1 |
Suzuki, N | 1 |
Ono, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Status of the Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis in Relation to Growth Failure, Body Weight and Neuroprotection in Children With Ataxia Telangiectasia[NCT01052623] | Phase 4 | 24 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for serine and Ataxia Telangiectasia
Article | Year |
---|---|
[Low-dose radiation effects and intracellular signaling pathways].
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA Damage; DNA- | 2006 |
21 other studies available for serine and Ataxia Telangiectasia
Article | Year |
---|---|
MRE11 stability is regulated by CK2-dependent interaction with R2TP complex.
Topics: Animals; Apoptosis Regulatory Proteins; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Protein | 2017 |
RAD50 phosphorylation promotes ATR downstream signaling and DNA restart following replication stress.
Topics: Acid Anhydride Hydrolases; Ataxia Telangiectasia; Cell Line; Checkpoint Kinase 1; DNA Breaks, Double | 2014 |
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Carnitine O-Palmitoyltransferase; Cel | 2009 |
Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity.
Topics: Adult; Alanine; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Blood Cells; Blotting | 2004 |
Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells.
Topics: Amino Acid Sequence; Androstadienes; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; | 2004 |
Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalytic Domain; Cell Cycle Proteins | 2004 |
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Topics: Animals; Antioxidants; Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cel | 2005 |
DNA damage induces phosphorylation of the amino terminus of p53.
Topics: Ataxia Telangiectasia; Binding Sites; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin | 1997 |
Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.
Topics: Acetylcysteine; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; | 1999 |
The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalysis; Cell Cycle Proteins; DNA; | 1999 |
Ionizing radiation activates the ATM kinase throughout the cell cycle.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell | 2000 |
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; DNA; | 2000 |
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Chrom | 2000 |
ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catalysis; Cell Cycle Proteins; Cell | 2000 |
ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell | 2000 |
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; Cell Cycle; Cell Cycle | 2000 |
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Animals; Ataxia Telangiectasia; Ataxia Telangiectas | 2000 |
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
Topics: Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Pro | 2001 |
Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia | 2001 |
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Cells | 2001 |
Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.
Topics: Androstadienes; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycl | 2002 |